Disc Medicine, Inc. Common Stock

IRONNASDAQ • USD
80.00 USD
↘ 3.23 (3.88%)AT CLOSE (03:59 PM EST)
81.20
↗ 1.20 (1.50%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
81.20
↗ 1.20 (1.50%)
🔴Market: CLOSED

Disc Medicine, Inc. Common Stock (IRON) is currently trading at $80.00. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation metrics place IRON at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$83.00
High?$83.00
Low?$79.73
Prev. Close?$83.23
Volume?779.9K
Avg. Volume?1.4M
VWAP?$80.68
Rel. Volume?0.57x
Bid / Ask
Bid?$77.50 × 200
Ask?$82.80 × 200
Spread?$5.30
Midpoint?$80.15
Valuation & Ratios
Market Cap?3.6B
Shares Out?45.5M
Float?32.7M
Float %?85.3%
P/E Ratio?N/A
P/B Ratio?6.03
EPS?-$5.34
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Employees
173
Market Cap
3.6B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-02-08
Address
321 ARSENAL STREET, SUITE 101
WATERTOWN, MA 02472
Phone: (617) 674-9274
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
65
Short Sent.?
56
Piotroski F-Score?0/9Weak
Altman Z-Score?21.45Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?20.96%Squeeze Risk
Short Interest?6.9M
Days to Cover?3.2
Free Float32.7M
Avg Daily Volume2.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?20.30Strong
Quick Ratio?20.30Strong
Cash Ratio?2.62Strong
Debt/Equity?0.10Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
30
6.03FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-13.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-40.2%WEAK▾
ROA?
S&P
3
-34.8%WEAK▾
Cash Flow & Enterprise
FCF?$-189959000
Enterprise Value?$3.6B
Fundamentals ratios updated end of day